Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Joyce Afrakoma Obeng"'
Autor:
Maria Talmon, Marcella Percio, Joyce Afrakoma Obeng, Federico A Ruffinatti, Daniele Sola, Pier Paolo Sainaghi, Emanuela Bellis, Stefano Cusinato, Aurora Ianniello, Luigia G Fresu
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0282564 (2023)
It is well documented that patients affected by rheumatoid arthritis (RA) have distinct susceptibility to the different biologic DMARDs available on the market, probably because of the many facets of the disease. Monocytes are deeply involved in the
Externí odkaz:
https://doaj.org/article/8a07627c28684939a2c153b3f51db3de
Autor:
Angela Amoruso, Sandra Brunelleschi, Daniele Sola, L. Fresu, Joyce Afrakoma Obeng, Gian Luca Ermanno Camaschella
Publikováno v:
European Journal of Pharmacology. 780:33-37
Tocilizumab, etanercept and abatacept are biological drugs used in the therapy of Rheumatoid Arthritis (RA). Their mechanism of action is well documented but their direct effects on human monocytes/macrophages have not been fully investigated. The ob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc135f898ce6fbc844c6aed9a45ebc47
https://doi.org/10.1016/j.ejphar.2016.03.028
https://doi.org/10.1016/j.ejphar.2016.03.028
Autor:
Jane Wrigley, Rajendra Kumari, Jason R. King, Maya Jetha, Yinfei Yin, Simon Jiang, Joyce Afrakoma Obeng
Publikováno v:
Cancer Research. 79:87-87
BACKGROUND: Checkpoint inhibitors have shown promising therapeutic benefit in various cancer types, but more advanced preclinical models are required to combat resistance and evaluate opportunities for combination treatments. Subcutaneous syngeneic m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e95bc2fcec8ddd0d24940b697459661
https://doi.org/10.1158/1538-7445.am2019-87
https://doi.org/10.1158/1538-7445.am2019-87
Autor:
Angela Amoruso, Luca Rossi, Joyce Afrakoma Obeng, Sandra Brunelleschi, Pier Paolo Sainaghi, Daniele Sola, Luigia Grazia Fresu, Mario Pirisi
Publikováno v:
Pharmacological research. 107
Circulating human monocytes, a functionally and phenotypically heterogeneous population, are emerging as fundamental cell types in rheumatoid arthritis (RA). The aim of this pilot study was to assess the correlation, if any, among anti-rheumatic drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bd284ad7b95a163200dadb1b0e02cea
https://pubmed.ncbi.nlm.nih.gov/27045818
https://pubmed.ncbi.nlm.nih.gov/27045818